102 However, various teams are advocating for the incorporation of novel markers, such as a sophisticated karyotype55 or epigenetic subsets, 27,28 into clinical observe. All these novel prognostic and/or predictive models will have to be validated in cohorts of sufferers taken care of with specific brokers.Some diploma of immunophenotype overlap am